Volume | 0 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | Mínimo Máximo |
||||||
Minimo del Dia |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
NeuroBo Pharmaceuticals Inc | NRBO | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
3.68 |
Operaciones | Volume Operado de la Acción | Volumen promedio | Rango 52 semanas |
---|---|---|---|
0 | 0 | - | 2.8888 - 6.7499 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
- | 0 | US$ 3.68 | USD |
Información Financiera NeuroBo Pharmaceuticals Inc NRBO
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
17.85M | 4.85M | - | 0 | -12.47M | -2.57 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre NeuroBo Pharmaceuticals Inc NRBO
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
30/4/2024 | 07:01 | PR Newswire (US) | NeuroBo to Present Latest Pre-Clinical Data on.. |
17/4/2024 | 07:05 | PR Newswire (US) | NeuroBo Pharmaceuticals Doses First Patient in Its Phase 1.. |
01/4/2024 | 07:01 | PR Newswire (US) | NeuroBo Pharmaceuticals Completes Enrollment of Part 1 of.. |
28/3/2024 | 07:01 | PR Newswire (US) | NeuroBo Pharmaceuticals Reports Year End 2023 Financial.. |
13/3/2024 | 07:01 | PR Newswire (US) | NeuroBo Pharmaceuticals Receives Safety Review Committee.. |
04/3/2024 | 07:01 | PR Newswire (US) | NeuroBo Pharmaceuticals Appoints Seasoned Life Science.. |
04/3/2024 | 06:30 | Edgar (US Regulatory) | Form 8-K - Current report |
29/2/2024 | 07:30 | Edgar (US Regulatory) | Form 8-K - Current report |
29/2/2024 | 07:01 | PR Newswire (US) | NeuroBo Pharmaceuticals Receives First Site IRB Approval for.. |
14/2/2024 | 07:52 | Edgar (US Regulatory) | Form 8-K - Current report |
12/2/2024 | 07:01 | PR Newswire (US) | NeuroBo Pharmaceuticals to Participate in the BIO CEO &.. |
01/2/2024 | 07:30 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos NRBO
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 3.05 | 3.68 | 3.00 | 3.42 | 26,728 | 0.63 | 20.66% |
1 Month | 3.90 | 4.04 | 2.99 | 3.46 | 27,146 | -0.22 | -5.64% |
3 Months | 4.50 | 6.7499 | 2.99 | 5.36 | 122,119 | -0.82 | -18.22% |
6 Months | 3.28 | 6.7499 | 2.90 | 5.32 | 714,125 | 0.40 | 12.20% |
1 Year | 5.3832 | 6.7499 | 2.8888 | 5.00 | 487,193 | -1.70 | -31.64% |
3 Years | 854.40 | 1,576.80 | 2.8888 | 260.16 | 1,037,593 | -850.72 | -99.57% |
5 Years | 2,196.00 | 7,200.00 | 2.8888 | 321.69 | 750,712 | -2,192.32 | -99.83% |